Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Out-licensing
- View
BIO-006 - INFECTIOUS DISEASES - Compositions and Methods for Passive Immunity
Our passive immunity patent portfolio concerns the local or topical administration of monoclonal or polyclonal antibody compositions in the prevention and treatment of infectious disease.
Mechanism of action
Local or topical administration of human immunoglobulin compositions (IgA, IgM, IgG) to the surface of the skin or the surface of materials that come into contact with tissue or bodily fluids.
Full description
Summary of Invention:
Development status
Early Stage
Patent information
A number of patents and patent applications exist for this invention in the United States, Canada and Japan.
Type of business relationship sought
The technology is available for licensing and/or collaborative research and development with an industry partner.
Licensing contact
Mr. Todd Copeland
Manager
Technology Development/Commercialization
Manager
Technology Development/Commercialization
More information
For more information about the product please visit website.
Company details
LAWSON Business Development
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes.
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes.
Related reports
Are you looking for reports related to this particular subject. Our Reports section is the best place to start.
Related items
- Compositions and Methods for Increasing Recombinant Protein Yields Through the Modification of Cellular Properties
- Aerosolized Vaccines
- Use of Saccharides Cross-Reactive with Bacillus anthracis Spore Glycoprotein as a Vaccine Against Anthrax
- Phytohealth Corporation: PHN032 - Adjuvant for oral/nasal vaccines against influenza and bird influenza
- New detoxification method.
Related categories
- Industry sector
- Biotechnology / Human therapeutics
- Drug delivery / Topical / Dermatological
- Medical device / Therapeutic medical equipment / Surgical products
- Pharmaceutical
- Pharmaceutical / Prescription
- Therapeutic target
- Dermatological / Skin infection (other)
- Dermatological / Bacterial infection
- Dermatological / Wound healing
- Hospital and Surgery / Infection control
- Infectious diseases
- Infectious diseases / Nosocomial infections
- Infectious diseases / Diseases / Infection, viral (other)
- Infectious diseases / Treatments / Antibodies
- Infectious diseases / Treatments / Vaccine
- Infectious diseases / Diseases / Infection, bacterial(other)
- Infectious diseases / Diseases / Infectious disease (other)
- Infectious diseases / Treatments / Infection control
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us